Neostigmine

Back to search

Molecule Structure

Scientific Name

Neostigmine

Description of the Drug

Neostigmine is a cholinesterase inhibitor used in the symptomatic treatment of myasthenia gravis by improving muscle tone.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01400

Brand Name(s)

Not Available

Company Owner(s)

Fresenius Kabi Usa Llc, Par Sterile Products Llc, Caplin Steriles Ltd, Gland Pharma Ltd, American Regent Inc, Amphastar Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Exela Pharma Sciences Llc, Meitheal Pharmaceuticals Inc, Amneal Eu Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Acetylcholinesterase SINGLE PROTEIN INHIBITOR CHEMBL220

Unichem Links

SureChEMBL SCHEMBL34419
PharmGKB PA450611
Human Metabolome Database HMDB0015472
DrugBank DB01400
PubChem: Thomson Pharma 15121488
PubChem 4456
Mcule MCULE-3501840981
NMRShiftDB 20200212
LINCS LSM-5360
Nikkaji J4.797J
BindingDB 50022775
EPA CompTox Dashboard DTXSID1023360
DrugCentral 1897
Brenda 30362 2571 47472
ChemicalBook CB11351001
Guide to Pharmacology 8993
rxnorm BLOXIVERZ NEOSTIGMINE BROMIDE NEOSTIGMINE METHYLSULFATE NEOSTIGMINE
KEGG Ligand C07258
ChEBI 7514
ZINC ZINC000000001792